Elsevier

Sleep Medicine

Volume 35, July 2017, Pages 17-22
Sleep Medicine

Original Article
Women with symptoms of sleep-disordered breathing are less likely to be diagnosed and treated for sleep apnea than men

https://doi.org/10.1016/j.sleep.2017.02.032Get rights and content

Highlights

  • Female sleepy snorers are less often diagnosed with sleep apnea than men.

  • Females are less often treated for sleep apnea than men despite similar symptoms.

  • “Snoring and sleepiness” is a risk factor for hypertension and diabetes in both gender.

Abstract

Background

Women are often underrepresented at sleep clinics evaluating sleep-disordered breathing (SDB). The aim of the present study was to analyze gender differences in sleep apnea diagnosis and treatment in men and women with similar symptoms of SDB.

Methods

Respiratory Health in Northern Europe (RHINE) provided information about snoring, excessive daytime sleepiness (EDS), BMI and somatic diseases at baseline (1999–2001) and follow-up (2010–2012) from 4962 men and 5892 women. At follow-up participants were asked whether they had a diagnosis of and/or treatment for sleep apnea.

Results

Among those with symptoms of SDB (snoring and EDS), more men than women had been given the diagnosis of sleep apnea (25% vs. 14%, p < 0.001), any treatment (17% vs. 11%, p = 0.05) and CPAP (6% vs. 3%, p = 0.04) at follow-up.

Predictors of receiving treatment were age, BMI, SDB symptoms at baseline and weight gain, while female gender was related to a lower probability of receiving treatment (adj. OR 0.3, 95% CI 0.3–0.5).

In both genders, the symptoms of SDB increased the risk of developing hypertension (adj OR, 95% CI: 1.5, 1.2–1.8) and diabetes (1.5, 1.05–2.3), independent of age, BMI, smoking and weight gain.

Conclusions

Snoring females with daytime sleepiness may be under-diagnosed and under-treated for sleep apnea compared with males, despite running a similar risk of developing hypertension and diabetes.

Introduction

Sleep-disordered breathing (SDB) is a prevalent condition ranging from upper airway resistance to severe obstructive sleep apnea (OSA) with intermittent hypoxia and sleep fragmentation throughout the night. It is typically characterised by symptoms of loud snoring and excessive daytime sleepiness (EDS). Identifying at-risk patients is crucial, as treatment attenuates long-term health effects [1], [2], [3], and both snoring and OSA are associated with cardiovascular disease, stroke, diabetes mellitus and mortality [4], [5], [6], [7], [8], [9].

Community-based surveys reveal that SDB is about twice as common in men compared with women [10], [11], [12], [13], [14]. Women are, however, systematically underrepresented at sleep clinics, with only 20% or fewer females frequently represented in cohorts from clinical laboratories [2], [3], [15]. As a result, less is known about the long-term health effects of SDB in females. In a recent review, Won et al. concluded that, although the prevalence of SDB is lower in females, the consequences of the disease appear to be similar, or worse [16].

The reason why women are under-represented at sleep clinics is unclear. It has been speculated that the symptom profile of women with SDB differs from that of men [17], [18], but studies designed to identify specific SDB symptoms in women have failed [19], [20]. Instead, several studies have reported that snoring and EDS are the predominant symptoms in patients with OSA in both genders [15], [17], [19], [21]. However, women report EDS more frequently than men [22] and sleepiness might hence be a less reliable predictor for SDB in women than in men. Another possibility is that women may be less symptomatic at an early stage, as a result of which they are not referred for assessments of sleep apnea until they develop symptoms. The hypothesis is therefore that men and women with the same level of symptoms are diagnosed and treated to the same extent.

We aimed to analyze whether men and women in the community with symptoms of SDB (ie, snoring and daytime sleepiness) are equally diagnosed and treated for OSA. Another objective was to investigate whether snoring men and women with daytime sleepiness run the same risk of developing hypertension and diabetes mellitus.

Section snippets

Study population

The Respiratory Health in Northern Europe (RHINE) study II and III are the first and second follow-up of a population-based cohort from seven Northern European centres (Bergen in Norway; Umeå, Gothenburg and Uppsala in Sweden; Aarhus in Denmark; Reykjavik in Iceland and Tartu in Estonia) (www.rhine.nu). The cohort was initially recruited as part of the European Community Respiratory Health Survey (ECRHS) stage I (www.ecrhs.org). Random population samples of men and women born in 1945–73

Results

The study population comprised 4962 men and 5892 females aged 26–54 years at baseline. Men were generally somewhat older, more obese and reported hypertension and current smoking more often than women, while ex-smoking was overrepresented among women (Table 1). Snoring was reported by 25.9% of men and by 10.9% of women (p < 0.001). EDS was more common in females than males (23.8 vs. 18.4%, p < 0.001) but the prevalence of EDS was significantly higher among snorers compared with non-snorers in

Discussion

The main finding in this community-based prospective study is that women with SDB symptoms are less frequently diagnosed and treated for sleep apnea than men. We also found that men and women with SDB symptoms ran an equal increased risk of developing hypertension and diabetes mellitus.

There is no clear explanation of this gender difference in being diagnosed or treated for sleep apnea. As far as we know, there are no data supporting the hypothesis that snoring is associated with sleep apnea to

Conclusion

Snoring females with daytime sleepiness are less frequently diagnosed and treated for sleep apnea compared with males, despite running a similar risk of developing hypertension and diabetes mellitus. We recommend that physicians be more cognizant of sleep-disordered breathing in females and also ask females about symptoms of snoring and daytime sleepiness; referrals for those females with positive answers for sleep apnea recordings should also increase.

Authors' contributions

All authors have provided substantive contribution in study design, data collection and interpretation of results. Eva Lindberg performed the data analysis and wrote the first manuscript draft. All authors contributed substantially to revising the article critically for important intellectual content, and to final approval of the version to be published.

Acknowledgments

The work was performed at the Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Sweden. Eva Lindberg had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The Respiratory Health in Northern Europe study (RHINE) was funded by the Norwegian Research Council (Grant 214123), the Icelandic Research Council (Grant NA), Aarhus universitet (Grant 240008), the Swedish

References (43)

Cited by (46)

  • Evaluating symptoms and polysomnographic findings among male and female children with obesity with and without obstructive sleep apnea

    2022, Sleep Medicine
    Citation Excerpt :

    Males, on the other hand, present with the hallmark symptoms of OSA such as snoring, snorting, gasping and excessive daytime sleepiness as captured by an elevated ESS score [14,37]. As a result, females are less likely to be diagnosed with OSA [38]. Among children with obesity, we did not find differences in daytime sleepiness between males and females with OSA.

  • Sleep Measurements in Women

    2021, Sleep Medicine Clinics
    Citation Excerpt :

    The first assessment of a patient is typically not through a formal measurement but a clinical assessment based on history taking and a physical examination. If clinicians have preconceptions that make them less likely to suspect, for instance OSA in a woman, not for actual clinical reasons but the patient might not fit into the OSA stereotype of a middle-aged, overweight, sleepy man, they may be less likely to refer the patient to further examination.145–147 Taking narcolepsy as an additional example, both men and women can be affected, but there is a substantial sex difference in time from symptom onset to diagnosis.148

  • Sex Differences in Obstructive Sleep Apnea

    2021, Clinics in Chest Medicine
    Citation Excerpt :

    Obstructive sleep apnea (OSA) for many years has been thought to be a disease of men, but research performed more recently has revealed women are at significant risk for OSA as well as the morbidity associated with leaving it untreated. There are estimates that up to 90% of women with severe sleep apnea are not being diagnosed and that if diagnosed, they are less likely to be treated.1,2 This article will explore the sex differences in OSA, specifically addressing areas of prevalence, phenotypes, diagnostic criteria, and treatment.

  • Sleep Studies Interpretation and Application

    2020, Otolaryngologic Clinics of North America
View all citing articles on Scopus

All authors declare that the article submitted is not related to any financial interest/relationship.

View full text